Mission and Goals
The mission of the NCI’s Office of Cancer Genomics (OCG) is to enhance understanding of the molecular mechanisms of cancer, with the ultimate goal of improving the prevention, early detection, diagnosis, and treatment of cancer. Learn More
OCG Programs
Cancer Genetic Markers of Susceptibility (CGEMS)
CGEMS is an NCI enterprise initiative to conduct whole-genome association studies
to identify genes giving rise to risk of prostate and breast cancer....more
The Cancer Genome Anatomy Project (CGAP)
CGAP is an online resource designed to characterize biological tissues and provide
cDNA clones to the research community....more
The Cancer Genome Atlas (TCGA)
TCGA is a collaborative effort between the NCI and the NHGRI that will test the
feasibility of a large-scale systematic approach to identify genetic alterations
in human cancer....more
The Initiative for Chemical Genetics (ICG)
The ICG provides a systematic approach to study biology using such small molecules,
to develop new screening tools and compounds, and to accelerate the development
of new cancer strategies and therapies....more
The NIH Mammalian Gene Collection (MGC)
The goal of MGC is to provide full-length open reading frame (FL-ORF) clones for
human, mouse, and rat genes....more
Target Discovery and Development Network (TDDN)
The TDDN is a pilot program made possible by an investment from the American Recovery and Reinvestment Act. Members of the TDDN were chosen for the innovative approaches to molecular target discovery and validation....more
Therapeutically Applicable Research to Generate
Effective Treatments (TARGET)
The TARGET Initiative seeks to harness the power of modern genomics technologies
to rapidly identify valid therapeutic targets in childhood cancers so that new,
more effective treatments can be developed....more
Recent News
Funding Opportunity: RFP Announced for Next-Generation Sequencing Capacity
TARGET
October 1, 2009
Recovery Act Invests in New OCG Program
TDDN
October 1, 2009
Recovery Act Funds Addition of Three New Pediatric Cancers in TARGET Initiative
TARGET
September 24, 2009
Researchers Discover New Genetic Variation Linked to Prostate Cancer Risk
CGEMS
September 20, 2009
Mammalian Gene Collection Team Announces Completion of Resource
MGC
September 18, 2009
TARGET Researchers Identify Additional Mutations that Predict Relapse in ALL Patients
TARGET
June 9, 2009
Click here to read past news.
Funding
For more information about funding available through the Office of Cancer Genomics, click here.
Sign Up



